Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve please refer attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition Ltd has informed BSE that its Board of Directors will meet on Wednesday, November 12, 2025, in Mumbai. The main agenda is to consider and approve the unaudited financial results for the quarter ended September 30, 2025 (Q2 FY26). The filing was made under Regulation 29(1)(a) of SEBI's Listing Obligations and Disclosure Requirements. Additionally, the trading window for insiders in the company's equity shares will remain closed until November 14, 2025, in line with insider trading regulations.
This is a routine pre-results intimation with no actual numbers disclosed yet. Retail investors should wait for the November 12 outcome, as the unaudited Q2 results may influence short-term stock movement.